Lipitor Phase 4 Clinical Trial in Hypercholesteremia Patients With Yellow Coronary Plaque

To evaluate the efficacy of intensive lipid-lowering therapy with Lipitor on the changes of characteristics of yellow coronary plaque in subjects with hypercholesteremia accompanying coronary artery disease

Inclusion Criteria:

• Patients with hypercholesteremia
• The indication of coronary angiography, coronary angioscopy and intravascular ultrasound are expected

Exclusion Criteria:

• Patients who has current administration of Lipitor or history of discontinued administration of Lipitor
• Acute cardiac infarction